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OBJECTIVE — We examined the predictive value of hyperinsulinemia in the basal state on
the 24-year progression from normoglycemia to dysglycemia.
RESEARCH DESIGN AND METHODS — A sample of 515 normoglycemic men and
women were studied again after 24 years for glycemic status.
RESULTS — Half of the participants developed dysglycemia: 11.1% progressed to impaired
fastingglucose(IFG),9.9%toimpairedglucosetolerance(IGT),4.5%tobothIFGandIGT,and
another 24.3% to type 2 diabetes. Elevated levels of overnight fasting (basal) insulin, triglycer-
ides, BMI 27 kg/m
2, fasting blood glucose, blood pressure, North African or Yemenite back-
ground,andmalesexeachfavoredconversiontodysglycemiaafter24years.Inmultipleordered
logistic regression analysis, the most signiﬁcant predictor of progression to dysglycemia was
hyperinsulinemia (upper quintile), after adjusting for BMI, ethnic origin, sex, age, smoking,
physical activity, blood pressure, and triglycerides.
CONCLUSIONS — Basal hyperinsulinemia in normoglycemic adults constitutes an inde-
pendent risk factor for developing dysglycemia over 24 years.
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T
his study examined hyperinsulin-
emia in the basal state as an inde-
pendent factor associated with the
24-year progression to dysglycemia (im-
paired fasting glucose [IFG]/impaired
glucose tolerance [IGT] or type 2 diabe-
tes) in normoglycemic ethnically diverse
adult men and women.
In the 1980s, Modan et al. (1,2), fol-
lowing the analysis of baseline informa-
tion of the present cohort, proposed that
hyperinsulinemia, reﬂecting peripheral
insulin resistance, is linked to hyperten-
sion, obesity, dyslipidemia, and glucose
intolerance, a cluster termed “metabolic
syndrome” by Reaven (3). Insulin resis-
tance has since been assigned a central
place in the metabolic disturbances asso-
ciated with obesity and type 2 diabetes.
We previously reviewed the evidence for
the possible role of hyperinsulinemia, espe-
cially in the basal state, in sustaining, ex-
panding, or initiating insulin resistance (4).
RESEARCH DESIGN AND
METHODS— The current analysis
covers 515 survivors of a longitudinal
study to which a 2-h oral glucose toler-
ance test was done 24 years earlier and at
follow-up, when mean age was 70.4 
7.0 years. Study population, sampling,
and laboratory procedures were previ-
ously described (1,5). The study was ap-
proved by the institutional review board
of the Sheba Medical Center. All subjects
gave written informed consent.
Hyperinsulinemia in the basal state
was deﬁned as fasting insulin levels at
baseline in the upper quintile (Q5) of the
study sample. The group reported here
(followedupwithin2000–2005)wereall
“normoglycemic” in 1980, based on fast-
ing plasma glucose 110 mg/dl and 2-h
plasma glucose 140 mg/dl. The potas-
sium ferricyanide method used in 1980
overestimatesglucosevaluesby9%(6).
Thus, the 110 cutoff of 1980 is approxi-
mately equal to the 100 cutoff used at fol-
low-up. “Dysglycemia” was based on a
follow-up oral glucose tolerance test
and/or fasting glucose or if a subject re-
ported using hypoglycemic medications.
Baseline differences, between the normo-
glycemic and dysglycemic groups at fol-
low-up, were tested using the 
2 test for
categorical variables and the one-way
ANOVA for continuous variables. Ad-
justed multiple ordered logistic regres-
sion models with dummy variables for
ethnicity explored predictors for IFG/IGT
and diabetes.
RESULTS— Over the 24 years of the
study, half of the cohort maintained nor-
mal glucose tolerance (n  259; 50.3%).
Theotherhalfprogressedtodysglycemia,
evenlydividedbetweenthoseintheinter-
mediate categories (designated IFG 
11.1%; IGT  9.9%; IFG plus IGT 
4.5%) and those who fulﬁlled criteria for
type 2 diabetes (n  125; 24.3%). Dys-
glycemia was more common in men than
in women (56.0 vs. 43.4%, respectively;
P  0.01). Ethnicity also contributed;
participants originally from North Africa
and Yemen were more likely to develop
dysglycemia than those from Europe or
America (60.5 vs. 44.4%, respectively;
P  0.002). Higher values of basal insu-
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atbaseline,aswellashighervaluesoffast-
ing glucose, were each predictive of dys-
glycemia 24 years later.
In the logistic regression analysis, the
most signiﬁcant predictor for progression
to type 2 diabetes was hyperinsulinemia
in the basal state (upper quintile, Q5),
while fasting glucose was the strongest
predictor for IFG/IGT. BMI 27 kg/m
2
wasastatisticallysigniﬁcantpredictorofdi-
abetesonly,afteradjustingforsex,age,eth-
nicity, smoking, physical activity, blood
pressure, and triglycerides (Table 1).
CONCLUSIONS — The present
study is a late installment of results of a
large survey, inaugurated in the early
1980s, that called attention to links be-
tween hyperinsulinemia, insulin resis-
tance, dysglycemia, hypertension,
obesity, and hyperlipidemia (1,2). Basal
insulin was the strongest predictor for
progression to type 2 diabetes over 24
years. Whereas ethnicity and higher val-
ues of basal insulin, triglycerides, BMI,
blood pressure, fasting glucose, and male
sex were each predictive of dysglycemia
24 years later, in the multiple regression
model, the most statistically signiﬁcant
risk factor was basal insulin, reinforcing
its importance as a chief component and
perhapsadominantfactorinthedevelop-
ment of type 2 diabetes.
Possible shortcomings of our study
include remoteness of the outcome as-
sessment from the baseline measurement
causing inadequate information on med-
ications,lifestylechanges,andtimeofon-
set of dysglycemia. Survival bias may
affect the estimated links between basal
hyperinsulinemia and dysglycemia, most
likely attenuating them. A single baseline
measurement of BMI has probably in-
creased the magnitude of the association
between obesity and the outcome of
dysglycemia.
Our study has several strengths: the
deﬁnition of normoglycemia was based
on both fasting and 2-h postload glucose
values,leavingoursampleunconfounded
by dysglycemia at baseline. The long fol-
low-up period of 24 years, as well as the
advanced age of subjects at follow-up, al-
lowed us to report actual rates of dysgly-
cemia. Finally, our cohort is of a well-
chosen sample randomly selected from a
national population registry, representa-
tive of the population with an equal num-
ber of men and women.
In our cohort, association between
fasting plasma glucose and basal plasma
insulin was weak with a correlation coef-
ﬁcient of 0.1 but was still statistically sig-
niﬁcant (P  0.02), likely because of the
large sample size. This suggests that, in
this group of normoglycemic subjects, in
the basal state, the absolute glucose value
has a limited effect on basal insulin level.
Weconcludethatinsubjectswithnormo-
glycemia, basal insulin in the upper quin-
tile confers an increased risk for the
development of glucose dysmetabolism.
Wesuggestthatin“normal”subjects,fast-
ing glucose and basal insulin are markers
of different pathways to an overlapping
group of disease processes.
Marked hyperinsulinemia is a com-
mon characteristic of several ethnic
groupswithahighprevalenceofdiabetes,
including Mexican Americans (7), Paciﬁc
Islanders (8), Native Americans (9), and
African Americans (10), even at an early
age (10–14). Identifying individuals
whose glucose tolerance will most likely
progress over the years to dysglycemia
would be of great public health beneﬁt.
Thus, a basal insulin measurement may
turn out to be a useful adjunct in at-risk
individuals with normal or near-normal
glycemia. We provide here long-term ep-
idemiologicalevidencethathyperinsulin-
emia in the basal state may relate to the
rootcauseoftype2diabetes.Theincreas-
ing prevalence of hyperinsulinemia, par-
ticularly among groups such as young
adults and non-Hispanic white women
(15), in light of our ﬁndings, is alarming.
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Table 1—Multiple ordered logistic regression model to predict progression to IFG/IGT or type 2 diabetes in a 24-year follow-up
Predictor Reference category
Predictor
prevalence (%)
Odds ratio
(IFG/IGT)
95% CI
(IFG/IGT)
Odds ratio
(type 2 diabetes)
95% CI
(type 2 diabetes)
Fasting insulin Q5 Q1–Q4 103 (20) 1.67 0.94–2.95 1.98 1.13–3.48
BMI 27 kg/m
2 27 kg/m
2 125 (24.3) 1.33 0.77–2.27 1.86 1.10–3.14
Ethnic origin Europe/America 216 (41.9)† 1.0 — 1.0 —
Yemen 96 (18.6) 1.58 0.83–2.99 1.84 1.0–3.41
Middle East 127 (24.7) 1.11 0.62–1.98 0.64 0.34–1.18
North Africa 76 (14.8) 2.65 1.38–5.11 1.51 0.75–3.04
Fasting blood glucose, Q5 Q1–Q4 103 (20) 1.99 1.10–3.61 1.67 0.90–3.09
Male sex Female 259 (50.3) 1.40 0.88–2.23 1.47 0.91–2.37
Blood pressure 130/85 mmHg 130/85 mmHg 157 (30.5) 1.57 0.96–2.58 1.49 0.91–2.46
Triglycerides 150 mg/dl 150 mg/dl 124 (24.1) 0.93 0.53–1.63 1.67 0.99–2.82
Sedentary‡ Physically active 215 (41.7) 1.49 0.94–2.36 1.11 0.69–1.78
Ever smoked Never smoked 202 (39.2) 1.03 0.64–1.67 1.22 0.75–1.97
Age 10-year increments — 0.75 0.54–1.06 0.84 0.60–1.18
*IFG/IGT  IFG or IGT or IFG  IGT. Q, quintile. †Prevalence of European/American in the sample. ‡Physical activity level at follow-up was used as a proxy for
the level of physical activity at baseline: Subjects who reported doing no leisure-time physical activity during follow-up were categorized as “sedentary” and those
who reported practicing any type of any duration of intentional physical activity were categorized as “physically active.”
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